pinane-thromboxane-a2 and Shock--Traumatic

pinane-thromboxane-a2 has been researched along with Shock--Traumatic* in 1 studies

Other Studies

1 other study(ies) available for pinane-thromboxane-a2 and Shock--Traumatic

Article	Year
Protective effects of a novel thromboxane analog in lethal traumatic shock. Prostaglandins and medicine, 1979, Volume: 3, Issue:3 Pinane thromboxane A2 (PTA2) an analog of thromboxane A2 that inhibits the formation of thromboxanes as well as antagonizes their biological actions, at an infusion rate of 1.0 mumole . kg-1 . h-1, prolonged survival in traumatic shock in rats. PTA2 also prevented the accumulation of thromboxane B2, the lysosomal protease, cathepsin D, and the cardiotoxic peptide MDF in the circulating blood. Topics: Animals; Bicyclic Monoterpenes; Cathepsins; Myocardial Depressant Factor; Rats; Shock, Traumatic; Thromboxane A2; Thromboxane B2; Thromboxanes	1979

Article

Year

Protective effects of a novel thromboxane analog in lethal traumatic shock.

Prostaglandins and medicine, 1979, Volume: 3, Issue:3

Pinane thromboxane A2 (PTA2) an analog of thromboxane A2 that inhibits the formation of thromboxanes as well as antagonizes their biological actions, at an infusion rate of 1.0 mumole . kg-1 . h-1, prolonged survival in traumatic shock in rats. PTA2 also prevented the accumulation of thromboxane B2, the lysosomal protease, cathepsin D, and the cardiotoxic peptide MDF in the circulating blood.

Topics: Animals; Bicyclic Monoterpenes; Cathepsins; Myocardial Depressant Factor; Rats; Shock, Traumatic; Thromboxane A2; Thromboxane B2; Thromboxanes

1979